Antitrust Antitrust

Servier's market-dominance court victory endangers antitrust law, EU Commission argues

By Nicholas Hirst
  • 21 Oct 2021 12:13
  • 21 Oct 2021 12:13
The price stability of Servier's blockbuster perindopril drug in the face of market developments is evidence of the French drugmaker's dominance, the European Commission argued today at the EU's top court.

It is trying to overturn a ruling by the General Court, which largely upheld a 2014 decision against Servier an

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Nicholas Hirst

Chief Correspondent


Nicholas covers EU merger review and antitrust investigations for Mlex in Brussels. He previously wrote about EU affairs for Politico Europe, European Voice and PaRR. After earning an LLM in European law from the College of Europe in Bruges, he spent a year working in the competition practice of a leading competition law firm in Brussels 2009-10. He graduated in modern European languages from Oxford University in 2006.

Discover MLex

Stay on top of global regulatory developments

Latest News